More PRNewswire
View Older Stories View Newer Stories-
U.S. Department of Energy Announces Generac Power Systems as Part of a $440 Million Commitment to Install Rooftop Solar and Batteries in Puerto Rico's Most Vulnerable Communities
-
ScrubaDub Expresses Gratitude to Veterans and Military Personnel on Veterans Day
-
SIGNET JEWELERS ANNOUNCES TIMING OF FISCAL 2024 THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
-
Securitas AB Interim Report Q3 2023 | January-September 2023
-
Agroforestry Coalition Releases Recommendations for the Farm Bill, Highlights Why Agroforestry Is a Priority Solution for Resilient Agriculture
-
Boston Centerless Partners with May River Capital
-
Greenstein & Milbauer, LLP Adds Fire Power with New Attorney Addition
-
Kexing Biopharm Attended CPHI Worldwide 2023
-
AWH ANNOUNCES Q3 2023 FINANCIAL RESULTS
-
Nationwide Electrify Expo Tour - Starring Award-winning Mitsubishi Outlander Plug-in Hybrid - Concludes in Austin, Texas, Nov. 10-12
-
Omigo is Now Brondell: Leading Manufacturer of Bidets in North America Consolidates DTC Start-Up, Strengthening Foothold in Bidet Marketplace and Expanding Customer Reach.
-
REGENXBIO to Participate in Upcoming Investor Conferences
-
Gryphon Investors' Vivify Acquires Access Ingredients, Expanding its Personal Care and Cosmetics Presence
-
Mill Creek Announces Groundbreaking of Modera Encore
-
Tradewind Finance Named Best Factoring Company Germany 2023 and Best NBFI Management Team Germany 2023
-
Gogo Announces Third Quarter Results
-
Delek US Holdings Reports Third Quarter 2023 Results
-
ZINFI Releases Complimentary Guidebook Providing an Overview of Best Practices in Partner Relationship Management
-
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric C
-
Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR
-
TransAlta Reports Third Quarter 2023 Results
-
HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2024 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 18% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEAR
-
WELL Health Announces Record Patient Visits and Total Care Interactions for Q3-2023 Resulting in Record Quarterly Revenue
-
Trina Solar wins prestigious international design award for Vertex S+
-
McDermott Awarded Transportation and Installation Contract by ONGC
-
GENAI DELIVERS AI COMPUTE EQUIPMENT TO CUSTOMER
-
Mandalay Resources Corporation Provides an Exploration Update on Shepherd and Brunswick Deeps Discovery
-
2023 WINNERS OF THE SIXTH-ANNUAL POINTS GUY AWARDS ANNOUNCED AT GALA IN NEW YORK
-
Zepp Health Corporation to Report Third Quarter 2023 Financial Results on November 20, 2023
-
AltLayer's infrastructure to support Cometh's latest Arbitrum-Orbit powered Layer 3 'Muster Network'
-
TÜV Rheinland Awards Product Carbon Footprint Certification to the Hisense Laser TV
-
CECO ENVIRONMENTAL REPORTS THIRD QUARTER 2023 RESULTS
-
Touchstone Essentials' New Packaging Shows Commitment to Sustainability
-
Vistra Reports Third Quarter 2023 Results; Initiates 2024 Guidance
-
CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM
-
Datadog Announces Third Quarter 2023 Financial Results
-
Remix Therapeutics Announces Participation in Jefferies London Healthcare Conference
-
Harvest Partners Closes Harvest Partners IX, L.P. With Over $5.3 Billion Of Commitments
-
21.co Marks 5th Anniversary with Remarkable Expansion and Unprecedented Growth
-
SolvEat's Botanical Composition Supports Blood Sugar Balance in A Chocolate Delight
-
Syndax Announces Participation at Stifel Healthcare Conference
-
Embroker Selects Ascend to Revolutionize the Insurance Industry Through Transformative Technology
-
Get Cozy This Hot Cocoa Season With The Swiss Miss® Candier® Candle
-
HCI Equity Partners Announces Recapitalization of Tri-State Enterprises, Inc.
-
Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates
-
Eventus boosts security posture through successful SOC 2® Type 2 examination
-
Myrror Security Emerges from Stealth with $6M Seed Round to Prevent Attacks on the Software Development Process with AI-Backed Binary-to-Source Analysis Technology
-
Compugen Reports Third Quarter 2023 Results
-
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
-
BDR's Trailblazer Sales Academy Empowers Territory Managers With Key Leadership and Sales Skills
